Hims & Hers Health Analyst Ratings
BenzingaApr 16 06:46 ET
Hims & Hers Health Analyst Ratings
BenzingaApr 10 07:49 ET
Hims & Hers Health Outperforms: Strong Sales Growth and Brand Value Reinforce Buy Rating
TipRanksApr 10 06:15 ET
Analysts Offer Insights on Healthcare Companies: Regulus (RGLS), Hims & Hers Health (HIMS) and Olink Holding (OLK)
TipRanksMar 27 03:01 ET
Tigress Financial Boosts Price Target on Hims & Hers Health to $19 From $15, Cites Move to Accelerated Growth Phase, Keeps Buy Rating
MT NewswiresMar 1 06:59 ET
Analysts Conflicted on These Healthcare Names: ACADIA Pharmaceuticals (ACAD), Hims & Hers Health (HIMS) and Amylyx Pharmaceuticals Inc (AMLX)
TipRanksFeb 28 00:01 ET
Deutsche Bank Adjusts Hims & Hers Health Price Target to $14 From $8, Maintains Hold Rating
MT NewswiresFeb 27 10:30 ET
Hims & Hers Health Analyst Ratings
BenzingaFeb 27 08:56 ET
Analysts Are Bullish on Top Healthcare Stocks: Bruker (BRKR), Hims & Hers Health (HIMS)
TipRanksFeb 27 08:10 ET
Truist Financial Reaffirms Their Hold Rating on Hims & Hers Health (HIMS)
TipRanksFeb 27 07:48 ET
Hims & Hers Health (HIMS) Gets a Hold From Piper Sandler
TipRanksFeb 27 07:44 ET
Hims & Hers Health Analyst Ratings
BenzingaFeb 26 08:42 ET
Truist Financial Keeps Their Hold Rating on Hims & Hers Health (HIMS)
TipRanksJan 7 21:26 ET
Robust Growth and Strategic Positioning Underscore Buy Rating for Hims & Hers Health
TipRanksJan 5 10:05 ET
Hims & Hers Health Analyst Ratings
BenzingaJan 5 10:02 ET
Tigress Financial Raises Price Target on Hims & Hers Health to $15 From $14, Maintains Buy Rating
MT NewswiresJan 5 10:00 ET
Hims & Hers Health (HIMS) Receives a Hold From Piper Sandler
TipRanksJan 3 07:52 ET
Truist Financial Reaffirms Their Hold Rating on Hims & Hers Health (HIMS)
TipRanksNov 8, 2023 21:30 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Crispr Therapeutics AG (CRSP), Amneal Pharmaceuticals (AMRX) and Hims & Hers Health (HIMS)
TipRanksNov 8, 2023 21:30 ET
Deutsche Bank Adjusts Hims & Hers Health Price Target to $8 From $11, Maintains Hold Rating
MT NewswiresNov 8, 2023 10:50 ET
No Data
No Data